Pfizer, Arcadium Lithium, Richemont
On Oct. 6, The Wall Street Journal reported that activist investor group Starboard Value owns a stake in Pfizer ( PFE -0.61%) ...
In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Pfizer (PFE – Research Report), with a price ...
Pfizer's stock is poised for growth with strong technical and fundamental indicators, promising pipeline, and Seagen ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Leerink Partners analyst David Risinger has maintained their neutral stance on PFE stock, giving a Hold rating on October 7. David ...
On top of this, Pfizer also faces key patent expirations of certain older products, and earlier estimated this will result in ...
Lower interest rates make these stand-out dividend payers must-see investments for those who want passive income.
U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Monday. Shares of Pfizer Inc PFE rose during ...
We recently compiled a list of the 7 Best Stocks to Buy for Passive Income. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other good stocks to ...
Pfizer Inc. (PFE) announced Friday that the U.S. Food and Drug Administration has approved HYMPAVZI (marstacimab-hncq) for routine ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback